Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Nemus Bioscience, Inc. (NMUS) Starts Presentation at LD Micro Conference

Nemus Bioscience is a biopharmaceutical company with a focus on the discovery, development and commercialization of therapeutics based on naturally-derived or synthetically manufactured cannabis compounds. The company develops therapeutic products to treat glaucoma and other optic nerve-related disorders and conditions associated with muscle spasticity, epilepsy, anxiety, and methicillin-resistant staphylococcus aureus. Founded in 2012, the company is based in Costa Mesa, California. For more information, visit the company’s website at

The three-day LD Micro Invitational in Bel Air, California, features company presentations from more than 200 select high-potential small-cap companies spanning multiple industries. Institutional and retail investors in attendance also have access to numerous networking opportunities and social events to learn more about these companies. For more information on LD Micro, visit
This entry was posted in LD Micro Conference. Bookmark the permalink.

Comments are closed.